This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1988 Oct 22;2(8617):973.

doi: 10.1016/s0140-6736(88)92650-5.

Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease

S Nishihara, K Ishibashi, K Iribe, I Matsuda

PMID: 2459575
DOI: 10.1016/s0140-6736(88)92650-5

Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease

S Nishihara et al. Lancet. 1988.

. 1988 Oct 22;2(8617):973.

doi: 10.1016/s0140-6736(88)92650-5.

Authors

S Nishihara, K Ishibashi, K Iribe, I Matsuda

PMID: 2459575
DOI: 10.1016/s0140-6736(88)92650-5

No abstract available

PubMed Disclaimer

Similar articles

High-dose intravenous gammaglobulin for Kawasaki disease.
Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, et al. Furusho K, et al. Lancet. 1984 Nov 10;2(8411):1055-8. doi: 10.1016/s0140-6736(84)91504-6. Lancet. 1984. PMID: 6209513 Clinical Trial.
Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities.
Marasini M, Pongiglione G, Gazzolo D, Campelli A, Ribaldone D, Caponnetto S. Marasini M, et al. Am J Cardiol. 1991 Sep 15;68(8):796-7. doi: 10.1016/0002-9149(91)90658-8. Am J Cardiol. 1991. PMID: 1716411 No abstract available.
High-dose gammaglobulin therapy for Kawasaki disease.
Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura N. Nagashima M, et al. J Pediatr. 1987 May;110(5):710-2. doi: 10.1016/s0022-3476(87)80007-0. J Pediatr. 1987. PMID: 2437278 Clinical Trial.
New developments in Kawasaki disease.
Leung DY. Leung DY. Curr Opin Rheumatol. 1991 Feb;3(1):46-55. doi: 10.1097/00002281-199102000-00009. Curr Opin Rheumatol. 1991. PMID: 1710476 Review.
Kawasaki syndrome.
Rowley AH, Gonzalez-Crussi F, Shulman ST. Rowley AH, et al. Adv Pediatr. 1991;38:51-74. Adv Pediatr. 1991. PMID: 1718150 Review. No abstract available.

See all similar articles

Cited by

IgG levels in Kawasaki disease and its association with clinical outcomes.
Yamazaki-Nakashimada MA, Gámez-González LB, Murata C, Honda T, Yasukawa K, Hamada H. Yamazaki-Nakashimada MA, et al. Clin Rheumatol. 2019 Mar;38(3):749-754. doi: 10.1007/s10067-018-4339-0. Epub 2018 Oct 20. Clin Rheumatol. 2019. PMID: 30343342
Intravenous immunoglobulin for the treatment of Kawasaki disease in children.
Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, Roman K, Dua JS, Flynn I. Oates-Whitehead RM, et al. Cochrane Database Syst Rev. 2003;2003(4):CD004000. doi: 10.1002/14651858.CD004000. Cochrane Database Syst Rev. 2003. PMID: 14584002 Free PMC article.
Intravenous immunoglobulin for the treatment of Kawasaki disease.
Broderick C, Kobayashi S, Suto M, Ito S, Kobayashi T. Broderick C, et al. Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2. Cochrane Database Syst Rev. 2023. PMID: 36695415 Free PMC article.
Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas.
Falcini F, Capannini S, Rigante D. Falcini F, et al. Pediatr Rheumatol Online J. 2011 Jul 20;9:17. doi: 10.1186/1546-0096-9-17. Pediatr Rheumatol Online J. 2011. PMID: 21774801 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information